Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Feb 4;3(1):5.
doi: 10.1186/2047-2994-3-5.

Predictors of hospital surface contamination with Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: patient and organism factors

Affiliations

Predictors of hospital surface contamination with Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: patient and organism factors

Joshua T Freeman et al. Antimicrob Resist Infect Control. .

Abstract

Background: The role of the hospital environment in transmission of ESBL-Klebsiella pneumoniae (ESBL-KP) and ESBL-Escherichia coli (ESBL-EC) is poorly defined. Recent data however suggest that in the hospital setting, ESBL-KP is more transmissible than ESBL-EC. We sought therefore to measure the difference in hospital contamination rates between the two species and to identify key risk factors for contamination of the hospital environment with these organisms.

Methods: We systematically sampled 8 surfaces in the rooms and bathrooms of adult patients colonized or infected with ESBL-EC or ESBL-KP throughout their hospital stay. Data were collected on factors potentially affecting contamination rates. Environmental contamination was defined as recovery of an ESBL-producing organism matching the source patient's isolate. Multivariate logistic regression analysis was performed at the level of the patient visit using generalized estimating equations to identify independent predictors of environmental contamination.

Results: 24 patients (11 with ESBL-KP, 11 ESBL-EC and 2 with both organisms) had 1104 swabs collected during 138 visits. The overall contamination rate was 3.4% (38/1104) and was significantly higher for ESBL-KP than ESBL-EC (5.4% versus 0.4%; p < 0.0001). After multivariate analysis, environmental contamination was found to be negatively associated with carbapenem exposure (OR 0.06 [95% CI 0.01-0.61]; p = 0.017) and positively associated with the presence of an indwelling urinary catheter (OR 6.12 [95% CI 1.23-30.37]; p = 0.027) and ESBL-KP in the source patient (OR 26.23 [95% CI 2.70-254.67]; p = 0.005).

Conclusions: Contamination of the hospital environment with ESBL-producing Enterobacteriaceae (ESBL-E) is inversely associated with carbapenem exposure. Predictors of hospital contamination with ESBL-E include: indwelling urinary catheters and ESBL-KP. Rooms of patients with ESBL-KP have substantially higher contamination rates than those with ESBL-EC. This finding may help explain the apparently higher transmissibility of ESBL-KP in the hospital setting.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Time line of visits for the 8 patients with at least one positive environmental swab. Figure 1 Legend: Rows 1–8 represent patients with at least one positive environmental sample. Columns 1–25 indicate visit number. Blank cells represent visits for which no environmental contamination was detected. BT = Basin tap, TS = Toilet seat, DH = Bathroom door handle, AC = Antecubital fossa, CB = Call bell, NT = Nightingale (over bed) table, BC = Bedside cabinet, BH = bathroom handrail. *Patient 2 was colonized with ESBL-EC alone and patient 8 was colonized with both ESBL-EC and ESBL-KP. The remaining patients were colonized with ESBL-KP alone.
Figure 2
Figure 2
Relative rates of contamination across the different sites sampled.

References

    1. Hoban DJ, Bouchillon SK, Hawser SP, Badal RE. Trends in the frequency of multiple drug-resistant Enterobacteriaceae and their susceptibility to ertapenem, imipenem and other antimicrobial agents: data from the Study for Monitoring Antimicrobial Resistance Trends 2002–2007. Diagn Microbiol Infect Dis. 2010;3:78–86. doi: 10.1016/j.diagmicrobio.2009.06.009. - DOI - PubMed
    1. Hawser SP, Badal RE, Bouchillon SK. et al.Monitoring the global in vitro activity of ertapenem against Escherichia coli from intra-abdominal infections: SMART 2002–2010. Int J Antimicrob Agents. 2013;3:224–228. doi: 10.1016/j.ijantimicag.2012.10.014. - DOI - PubMed
    1. Oteo J, Navarro C, Cercenado E. et al.Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long term care facilities and hospital institutions. J Clin Microbiol. 2006;3:2359–2366. doi: 10.1128/JCM.00447-06. - DOI - PMC - PubMed
    1. Rodriguez-Bano J, Picon E, Gijo P. et al.Community-onset bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis. Clin Infect Dis. 2010;3:40–48. doi: 10.1086/649537. - DOI - PubMed
    1. Siegel JD, Rhinehart E, Jackson M, Chiarello L. Management of multidrug-resistant organisms in healthcare settings, 2006. Am J Infect Control. 2007;3:165–193. - PubMed

LinkOut - more resources